Jennifer Doudna • UCSF Profiles

Jennifer Doudna, PhD

Title(s)	Professor, Cellular Molecular Pharmacology
School	School of Medicine
Address	Location Required
Phone	--
ORCID	0000-0001-9161-999X
vCard	Download vCard

Research

Research Activities and Funding

Identifying and inhibiting the SARS-CoV-2 packaging mechanism
NIH R21AI159666Jul 15, 2021 - Jun 30, 2023
Role: Principal Investigator

Cas9 RNP delivery to immune cells in vivo via molecular targeting
NIH UG3AI150552Aug 28, 2019 - Jul 31, 2022
Role: Co-Principal Investigator

Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems
NIH U01AI142817Aug 24, 2018 - Jul 31, 2023
Role: Principal Investigator

Center for Genome Editing and Recording
NIH RM1HG009490Aug 8, 2017 - May 31, 2022
Role: Principal Investigator

Minstrel HTUV Gallery 700 Automated Crystal Growth and Imaging System
NIH S10OD016268Jun 1, 2013 - May 31, 2015
Role: Principal Investigator

HCV IRES Control of Human Translational Initiation
NIH R56AI095687Sep 30, 2011 - Sep 29, 2012
Role: Principal Investigator

Program in Virus Translational Control
NIH P01GM073732Jun 1, 2006 - May 31, 2012
Role: Principal Investigator

Structure and Function of RNAi-related Nucleases
NIH R01GM073794Sep 1, 2005 - Mar 31, 2015
Role: Principal Investigator

Structure and Mechanism of Internal Ribosome Entry Sites
NIH R01GM065942Sep 1, 2002 - Aug 31, 2006
Role: Principal Investigator

Nucleic Acids Gordon Research Conference
NIH R13GM066300May 1, 2002 - Apr 30, 2003
Role: Principal Investigator

ASSEMBLY OF HIGHER ORDER STRUCTURE IN GROUP I RIBOZYMES
NIH R01GM056361Aug 1, 1997 - Jul 31, 2002
Role: Principal Investigator

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature. 2017 10 19; 550(7676):407-410. Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA. PMID: 28931002; PMCID: PMC5918688.

View in: PubMed Mentions: 436 Fields:
Sci Science
Translation:Humans Cells
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013 Feb 28; 152(5):1173-83. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. PMID: 23452860; PMCID: PMC3664290.

View in: PubMed Mentions: 1783 Fields:
Cel Cell Biology
Translation:Cells
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012 Aug 17; 337(6096):816-21. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. PMID: 22745249; PMCID: PMC6286148.

View in: PubMed Mentions: 5442 Fields:
Sci Science
Translation:Cells